How Do You Calculate Albumin Creatinine Ratio: Formula

The albumin-to-creatinine ratio is urine albumin divided by urine creatinine, measured on the same single sample. If your laboratory reports in millimoles, albumin comes in mg/L and creatinine in mmol/L, and the answer is in mg/mmol. If your laboratory reports in conventional units, both arrive in mg/dL, you convert the creatinine to grams, and the answer is in mg/g. Nothing else is involved. No timed collection, no jug in the fridge, no arithmetic beyond one division.

What makes the ratio worth understanding is that it is not really a measure of albumin at all. It is a measure of how leaky your kidney filters are, and it detects that leak years before blood tests notice anything. A person with a perfect blood creatinine and a perfect estimated filtration rate can have an ACR that already places them in a treatment category. That is the point of the test. If you want the parallel test that measures total protein rather than albumin, the protein-creatinine ratio calculation works the same way with a different numerator, and the normal values for that ratio are covered separately.

What the albumin-to-creatinine ratio actually measures

Healthy kidney filters are selective. Water, salts and small waste molecules pass through freely; large proteins are held back, partly by size and partly by electrical charge. Albumin is the most abundant protein in blood plasma, and a healthy filter lets almost none of it escape. Almost none is not zero, though. A normal adult loses somewhere in the region of 5 to 20 mg of albumin into the urine each day, which is a trivial amount against the roughly 60 grams circulating in the bloodstream.

When the filter is damaged, that leak grows. It grows quietly, in proportion to the damage, and it grows long before waste products start accumulating in the blood. That is what makes urine albumin such a useful early signal: it reports on the structural integrity of the filter, whereas blood creatinine reports on the filter’s throughput, and structure fails first.

So why not just measure the albumin concentration and be done with it? Because urine concentration varies enormously. Drink two litres of water and your urine is dilute, so every substance in it is diluted alongside. Go without fluid on a hot day and everything is concentrated several-fold. A urine albumin of 30 mg/L means something completely different in dilute urine than in concentrated urine, and a spot sample gives you no way of knowing which you have got.

Creatinine solves that problem, and it solves it elegantly. Your muscles produce creatinine at a nearly constant rate, hour after hour, and the kidneys excrete essentially all of it. That means the amount of creatinine appearing in your urine per day barely changes, regardless of how much you drink. What changes is the volume it is dissolved in. So urine creatinine concentration is, in effect, a dilution meter. Divide anything by it and you cancel the dilution out.

There is a second reason the ratio works so neatly, and it is a happy accident of arithmetic. An average adult excretes roughly one gram of creatinine per day. So if you express the ratio as milligrams of albumin per gram of creatinine, the number you get is approximately the number of milligrams of albumin you are losing in twenty-four hours. An ACR of 250 mg/g corresponds to roughly 250 mg of albumin a day. Nobody planned that; it falls out of human physiology, and it is why the mg/g convention is so intuitive to people who learned nephrology on 24-hour collections.

Why albumin specifically, rather than total protein

Urine contains dozens of proteins. Albumin is one of them, and for a long time the standard test measured all of them together as total protein. The shift to measuring albumin alone was deliberate, and the reasoning is worth understanding because it explains when each test is still used.

In the two conditions that cause most chronic kidney disease worldwide, diabetes and hypertension, the damage is to the glomerulus, the tiny tuft of capillaries that does the filtering. When a glomerulus becomes leaky, albumin is the protein that comes through first. It is abundant, it sits right at the size and charge threshold the filter is defending, and it is the most sensitive indicator that the barrier has started to fail. Non-albumin proteins in urine come mostly from the tubules downstream and from the urinary tract itself, and in early glomerular disease those barely change.

This is why national kidney guidance and the NIDDK guidance on testing for kidney disease both put the urine albumin test alongside the blood test rather than treating it as an optional extra. The practical consequence is a large difference in sensitivity. Total protein assays struggle to reliably detect small increases, and the reference range for total protein has enough width at the bottom that an early leak disappears into it. Albumin can be measured by immunoassay down to very low concentrations, so a rise from 8 mg/day to 60 mg/day, which is a meaningful and detectable signal of early diabetic kidney disease, shows up clearly on ACR and is essentially invisible on a protein-creatinine ratio.

There is one situation where the specificity of ACR is a liability rather than an asset. In myeloma, the abnormal protein flooding the urine consists of immunoglobulin light chains, which are not albumin. A patient can be losing grams of light chain per day and have a completely normal ACR. That is not a flaw in the test so much as a reason clinicians order the right test for the question, and it is why total protein has not disappeared from practice. The section on ACR versus PCR below goes through when each is chosen.

The calculation, unit by unit

There are two conventions in use worldwide and they produce numbers that differ by nearly ninefold, which is the single largest source of confusion around this test. Get the units right and everything else follows.

SI units: the mg/mmol calculation

Used across the UK, Ireland, Australia, New Zealand, Canada and much of Europe. The laboratory reports urine albumin in milligrams per litre and urine creatinine in millimoles per litre. You divide directly.

No conversion factor, no rearranging. If albumin is 38 mg/L and creatinine is 9.5 mmol/L, the ratio is 4.0 mg/mmol.

Conventional units: the mg/g calculation

Used in the United States and several other countries. Both analytes are reported in milligrams per decilitre, so the creatinine has to be converted from milligrams to grams before dividing. That is a division by 1,000, which is where the factor of 1,000 in the formula comes from.

The same calculation written the other way round, which some people find clearer: convert the creatinine to grams per decilitre by dividing by 1,000, then divide albumin by that. Albumin 3.2 mg/dL with creatinine 110 mg/dL gives 3.2 ÷ 0.110 = 29 mg/g.

Some American laboratories report urine albumin in mg/L rather than mg/dL, which trips people up because the units look mismatched. If albumin is in mg/L and creatinine in mg/dL, multiply the creatinine by 10 first to bring it to mg/L, then apply the same 1,000 factor. Always check the unit printed next to each number before doing anything; the numbers on their own will happily produce an answer that is out by a factor of ten.

Why the denominator is creatinine and not something else

Creatinine is not a perfect dilution marker, just a very good and very cheap one. Its excretion depends on muscle mass, so a heavily muscled 28-year-old man excretes considerably more creatinine per day than a frail 84-year-old woman, perhaps 2 grams against 0.6 grams. Both might be losing exactly 100 mg of albumin daily. Divide by their respective creatinine outputs and the young man’s ACR reads about 50 mg/g while the older woman’s reads about 167 mg/g. Same leak, threefold different ratio, and the difference is entirely in the denominator.

This is a genuine limitation rather than a technicality, and it runs in a predictable direction. High muscle mass pushes ACR down and can mask early albuminuria. Low muscle mass, frailty, advanced age, amputation and severe malnutrition push ACR up and can create the appearance of albuminuria where the absolute loss is modest. Some guidelines have used sex-specific thresholds for this reason, typically around 2.5 mg/mmol for men and 3.5 mg/mmol for women, since women have lower average muscle mass. Current international practice mostly uses a single threshold for simplicity, accepting the small loss of precision. If you want the fuller picture of what urine creatinine itself reflects, urine creatinine explained and normal urine creatinine values cover the denominator in its own right.

Six worked examples

Numbers make this concrete faster than explanation does. Each example below uses realistic laboratory values and shows the arithmetic in full.

Two things to notice across the set. First, the ratio moves over a range of nearly a thousandfold in real clinical practice, which is why the categories are spaced logarithmically rather than evenly. Second, the arithmetic is trivial and the interpretation is not. Getting a number is easy. Knowing whether it is real, and what to do about it, takes the rest of this page.

Converting between mg/mmol and mg/g

The conversion factor is 8.84, and it comes from chemistry rather than convention. One millimole of creatinine weighs 113.12 milligrams, because that is creatinine’s molecular weight. So one millimole is 0.11312 grams, and one milligram of albumin per millimole of creatinine is the same as one milligram per 0.11312 grams, which is 8.84 mg/g.

In practice people round to 9, or in a hurry to 10, and for most purposes that is fine. It stops being fine near a threshold. An ACR of 3.2 mg/mmol converts to 28 mg/g using the correct factor and to 32 mg/g if you multiply by 10, and those two numbers fall on opposite sides of the A1/A2 boundary.

You will have spotted something in that table. The published cut-offs are 3 and 30 mg/mmol, and 30 and 300 mg/g, but 3 × 8.84 is 26.5 and 30 × 8.84 is 265. The thresholds are not exact conversions of each other; they are rounded to memorable round numbers in each system. The consequence is small but real: the SI thresholds are marginally stricter than the conventional ones, so a person sitting between 26.5 and 30 mg/g would be classified A2 in the UK and A1 in the United States. Nobody worries much about this, because a result that close to a boundary should be repeated anyway, but it explains an inconsistency people occasionally notice and assume is an error.

The A1, A2 and A3 categories and what each one means

International kidney guidance divides ACR results into three bands. They are not arbitrary; each marks a point where the risk of kidney decline, cardiovascular events and death steps up measurably, and each carries different implications for what happens next.

Now what they actually mean, which the table cannot convey.

One detail that surprises people: the categories are defined on a single sample but the diagnosis is not. A single A2 result does not establish chronic kidney disease. Persistence does, conventionally demonstrated by at least two abnormal results out of three samples taken over three to six months. A great many one-off raised readings are transient and never repeat, which is covered in detail below.

Why ACR forms the second axis of kidney staging

For decades kidney disease was staged on filtration alone. You had a number, an estimated GFR, and it put you in one of five stages. That system was simple and it was also misleading, because two people with the same filtration rate can have wildly different futures depending on whether their kidneys are leaking.

Current international staging uses two axes. Filtration gives the G categories, G1 through G5, running from normal down to kidney failure. Albuminuria gives the A categories you have just read. Your stage is the intersection, written as something like G3aA2, and the risk of progression is read off the grid rather than from either axis alone. If the filtration side is unfamiliar, calculating GFR from creatinine explains where that number comes from, and creatinine clearance versus GFR covers why there are two different filtration measures at all.

Read across the top row and the point becomes obvious. Someone with a completely normal eGFR of 95 and an ACR of 400 mg/g is classified high risk. Someone with an eGFR of 50 and an ACR of 8 mg/g is classified moderate risk. The second person has lost nearly half their filtration and is in a lower risk band than the first, whose filtration is textbook normal.

That is not a quirk of the grid. The National Kidney Foundation’s explanation of eGFR and CKD stages sets out the same two-axis logic. It reflects what large population studies consistently show: albuminuria predicts progression to kidney failure, cardiovascular events and death at least as strongly as reduced filtration does, and the two predict independently. A modestly reduced eGFR in an older person with no albuminuria often represents stable, age-related decline that will never cause trouble. A high ACR represents active glomerular damage, which tends to keep going.

There is a practical corollary for anyone reading their own results. If you have been told your kidney function is fine on the basis of a blood test alone, and you have diabetes, high blood pressure, cardiovascular disease, a family history of kidney disease, or you are on long-term medications that affect the kidney, the ACR is the test to ask about. It is a urine pot and a single extra line on the request form. For what the blood side of the picture means when it does move, what a high creatinine means and creatinine levels in stage 1 kidney disease are the companions to this page.

Microalbuminuria, moderately increased albuminuria, A2: all the same thing

Few areas of medicine have generated as much unnecessary confusion as the naming of this test. Three different terms describe an identical finding, they are all still in circulation, and patients regularly receive letters using one word and results using another.

The term microalbuminuria was coined in the 1980s and served a real purpose at the time: it distinguished small increases in albumin, detectable only by the new sensitive immunoassays, from the gross proteinuria visible on a dipstick. It was retired by international guidance in 2012, for three reasons that are worth spelling out.

The replacement terminology, normal to mildly increased, moderately increased, and severely increased, describes what is happening without smuggling in an interpretation. It has been standard for over a decade. It has also not fully displaced the old vocabulary in day-to-day speech, laboratory report headers, or the names of test request codes, many of which still say “microalbumin”. If your result says microalbumin and your letter says A2, they are describing the same sample.

How the sample should be taken, and what invalidates it

This is where results are most often quietly ruined, and it takes ten seconds to get right.

Circumstances that invalidate a sample

Any of the following can push a result up enough to change its category, which means the sample should be deferred or the result interpreted with the circumstance in mind.

Postural proteinuria deserves its own paragraph because it is a classic trap in younger people. In this benign condition, protein and albumin leak while the person is upright and stop when they lie down. A sample taken at 3pm can be clearly abnormal while a first-morning sample from the same person, produced after eight hours horizontal, is entirely normal. It is most often seen in adolescents and young adults, it does not progress, and it needs no treatment. The only way to identify it is the first-morning sample, which is one more reason that is the recommended collection.

What raises ACR transiently, and why it must be excluded first

A raised ACR is not a diagnosis. It is a finding that needs a cause, and a surprisingly large share of first abnormal results turn out to be transient. Acting on one without excluding the obvious reversible explanations leads to unnecessary medication, unnecessary anxiety and occasionally an unnecessary referral.

The albumin leak in these situations is real, in the sense that albumin genuinely is passing into the urine. It is simply not caused by chronic kidney damage, and it stops when the trigger stops.

Dehydration deserves a specific mention because people assume it raises ACR, and it mostly does not. Dehydration concentrates the urine, which raises the albumin concentration, but it raises the creatinine concentration by a similar proportion, so the ratio largely cancels out. That is exactly the artefact the ratio was designed to remove. Severe dehydration can affect it through reduced kidney perfusion, and it certainly raises blood creatinine, but the two are different questions. Whether dehydration raises creatinine deals with the blood side, where the effect is much larger.

Confirming a raised result before anything changes

Albumin excretion varies day to day in the same person by a considerable margin, commonly cited as around 30 to 50 percent between samples. That variability is biological, not a laboratory failing, and it means a single result near a threshold carries limited information.

The standard approach reflects that. A raised random sample is repeated on a first-morning specimen. If that confirms, a further sample is taken to establish whether the finding persists over three months, since chronic kidney disease is by definition a chronic finding. Two abnormal results from three samples over three to six months is the usual bar.

Lowering a raised albumin-creatinine ratio

Here is the genuinely encouraging part. Albuminuria is one of the few things in kidney medicine that responds well and quickly to treatment, and reducing it is associated with slower loss of kidney function rather than merely a better-looking test result. The evidence for that link is strong enough that a reduction in albuminuria is now accepted by drug regulators as a valid surrogate endpoint in kidney trials.

Everything below is described at the level of treatment classes and general principles. None of it is a recommendation for you, none of it includes doses, and none of it should prompt you to start, stop or change any medicine. That conversation belongs with the clinician who knows your results, your other conditions and everything else you take.

Blood pressure control

The single highest-yield intervention. Pressure inside the glomerulus drives albumin through a damaged filter, and systemic blood pressure is transmitted directly into that capillary bed. Lowering it reduces the leak mechanically as well as slowing further damage. Targets are individualised and have tightened over the years, with many guidelines now aiming below 130/80 mmHg in people with albuminuria, lower than the general population target. Home monitoring often reveals a different picture from clinic readings, and it is worth doing if albuminuria is the reason pressure is being treated.

ACE inhibitors and angiotensin receptor blockers

These two classes are the cornerstone of treatment, and they work through more than blood pressure alone. Angiotensin II constricts the vessel leaving the glomerulus, raising pressure inside the filter. Blocking that pathway with an ACE inhibitor such as ramipril, lisinopril or enalapril, or with an angiotensin receptor blocker such as losartan, irbesartan or candesartan, relaxes that outflow vessel and drops intraglomerular pressure specifically. Albuminuria typically falls by around 30 to 40 percent, more than blood pressure reduction alone would explain.

Three points that come up constantly. First, the two classes are not combined; using an ACE inhibitor and an ARB together produces more side effects without better kidney outcomes, and that combination was abandoned after trials showed harm. Second, a modest rise in blood creatinine after starting one of these drugs is expected rather than alarming, because reduced filtration pressure is the mechanism of benefit, and a rise of up to around 30 percent is generally tolerated and monitored rather than treated as a reason to stop. Third, blood tests for creatinine and potassium are routinely checked a couple of weeks after starting or changing the drug, and this check is not optional.

SGLT2 inhibitors

The most significant addition to kidney treatment in a generation. Originally developed as diabetes drugs, agents such as dapagliflozin, empagliflozin and canagliflozin turned out to protect kidneys substantially, including in people without diabetes. They act partly by restoring a feedback signal at the tubule that tells the glomerulus to reduce its filtration pressure, which lowers albuminuria by roughly a third on top of what an ACE inhibitor or ARB achieves.

They produce the same counterintuitive early pattern: a small dip in eGFR in the first weeks, typically a few millilitres per minute, which then stabilises and is followed by slower long-term decline than without the drug. That initial dip is a sign the drug is doing what it is supposed to do, and stopping because of it is a recognised mistake.

Newer classes

Non-steroidal mineralocorticoid receptor antagonists, of which finerenone is the example in current use, reduce albuminuria and slow progression in people with type 2 diabetes and chronic kidney disease, with a different mechanism again, targeting inflammation and fibrosis. GLP-1 receptor agonists such as semaglutide have also shown kidney benefit in trial populations with type 2 diabetes and kidney disease. Whether any of these is appropriate for a given person depends entirely on their situation, and the field is moving quickly enough that guidance revises frequently.

Glucose control

In diabetic kidney disease, glucose is the upstream driver. High glucose damages the glomerular capillaries over years and also raises albumin leak acutely. Better control reduces both effects, and improvement in HbA1c is often followed by a measurable fall in ACR within months. Targets are individualised; tighter is not automatically better, particularly in older people or where hypoglycaemia is a risk.

Salt reduction

Undervalued, and it does something specific. A high salt intake blunts the antiproteinuric effect of ACE inhibitors and ARBs, so someone eating a lot of salt gets less benefit from the drug than the same person on a moderate intake. Reducing salt to around 5 to 6 grams a day, which is roughly 2 to 2.4 grams of sodium, amplifies the medication that is already being taken. Most of that salt comes from processed food, bread and eating out rather than the shaker on the table.

The rest of it

What does not work, despite persistent claims: no supplement, herbal preparation, detox regimen or specific food lowers albuminuria in any way that has been demonstrated. Some herbal products are directly nephrotoxic. If the general question of reducing kidney-related blood markers interests you, how to lower creatinine levels takes the same evidence-first approach to a related question, and preventing creatinine from rising covers the protective side.

How quickly ACR responds, and what a good response looks like

Faster than most people expect. The mechanisms involved are haemodynamic, meaning they change pressures rather than repair tissue, so the effect appears within weeks rather than years.

A good response is usually defined as a fall of at least 30 percent from the starting value, sustained on repeat testing. That figure is not arbitrary. Analyses across many trials show that a 30 percent reduction in albuminuria predicts a meaningfully lower rate of progression to kidney failure, which is why regulators accept it as a trial endpoint and why clinicians treat it as a target.

Two cautions about interpreting your own trend. First, given the day-to-day variability, a drop from 42 to 36 mg/g is not evidence of anything; it is noise. Look for changes of a third or more, on comparable samples, ideally first-morning ones. Second, a falling ACR is good news about the leak, not proof that filtration is preserved, so the eGFR is followed alongside it rather than instead of it.

Getting back into a lower category is genuinely possible, particularly from A2. Regression from moderately increased to normal albuminuria happens in a substantial proportion of people with early diabetic kidney disease who get good blood pressure, glucose and RAS blockade. It is less common from A3, though large reductions within A3 still change the trajectory. The trajectory is what matters, not the label.

ACR versus PCR: when each one is used

Both ratios exist, both are ordered, and the choice is not arbitrary. The short version is that ACR is the test for finding kidney disease and PCR is the test for measuring certain kinds of protein loss once found.

The two ratios do not convert into each other reliably. At high levels of loss, where nearly all the protein in the urine is albumin, the numbers converge and a rough relationship holds. At low levels the relationship falls apart completely, because a normal PCR can hide an abnormal ACR. Published conversion equations exist and are used in research, but they carry wide uncertainty at the low end, which is precisely where the clinical decision sits. If you have a PCR result and want to know your albumin category, the answer is to have an ACR measured rather than to convert.

A rough guide to the equivalent thresholds, presented with the caveat that these are approximations and not interchangeable values:

Note the offset at the normal end. PCR’s normal range sits higher than ACR’s because healthy urine contains non-albumin protein that ACR ignores entirely, chiefly Tamm-Horsfall protein secreted by the tubules. That baseline is what swamps the early albumin signal and makes PCR the less sensitive screening test. For the detail on that side of the pair, normal protein-creatinine ratio values and what causes a high protein-creatinine ratio go into it properly.

One more distinction worth knowing. A standard urine dipstick detects albumin reasonably well but only above roughly 150 to 300 mg/L, and it reads concentration rather than a ratio, so it is affected by how dilute the sample is. A negative or trace dipstick does not exclude category A2 albuminuria, and a dipstick showing protein in dilute urine can be a substantial leak. The dipstick is a screening tool for gross proteinuria, not a substitute for the ratio.

Mistakes people make with this test

Who should have an ACR measured, and how often

Screening is targeted rather than universal, because the yield in a low-risk population is small. The groups where annual testing is standard practice in most national guidance:

If you have none of those risk factors and no symptoms, routine ACR testing is not generally recommended, and a normal result would not change anything. The exception is anyone who has had an episode of acute kidney injury, since that raises the long-term risk of chronic disease and usually earns follow-up testing. The broader question of what causes kidney numbers to move in the first place is covered in what causes high creatinine levels, and the definition of the filtration measure itself in what creatinine clearance is.

Symptoms that change the urgency

Albuminuria in the A2 range causes no symptoms whatsoever, which is the whole reason for screening. Heavy albuminuria does, and certain accompanying features mean the situation needs assessing sooner rather than at the next routine appointment.

Less urgent but still worth reporting promptly: urine that foams persistently in the toilet bowl, visible blood in the urine, unexplained weight gain over days rather than weeks, or blood pressure that has become difficult to control. Persistent frothing in particular tends to appear once albumin loss is heavy, and people often notice it well before anyone checks a urine sample.

What raised albuminuria does not typically cause: pain, burning on passing urine, back pain, or a change in urine colour. Those point towards infection, stones or something else in the urinary tract rather than towards a leaking glomerulus, and they need their own assessment.

What happens after a confirmed raised result

Most people with confirmed A2 albuminuria are managed entirely in primary care. The pathway is straightforward: confirm persistence, check the filtration rate and blood pressure, review medications, start or optimise a kidney-protective drug if appropriate, address glucose and salt, and monitor at intervals determined by risk.

Referral to a kidney specialist becomes likely in a smaller group. Common triggers across national guidance include an ACR above roughly 70 mg/mmol, or around 700 mg/g, whatever the filtration rate; an ACR above 30 mg/mmol combined with persistent blood in the urine; a rapidly falling eGFR; suspected genetic kidney disease; uncontrolled blood pressure despite several medications; or any suggestion of a specific glomerular disease that might need a biopsy and immunosuppression.

Those thresholds vary between countries and between guidelines, and they are applied with judgement rather than mechanically. A young person with an ACR of 40 mg/mmol and no explanation is a more concerning referral than an 88-year-old with the same value, long-standing diabetes and stable filtration. Age, trajectory and context all feed into it.

Frequently asked questions